Burleson & Company, LLC Bristol Myers Squibb CO Transaction History

Burleson & Company, LLC

$384 Million
Q4 2022

A detailed history of Burleson & Company, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Burleson & Company, LLC holds 30,849 shares of BMY stock, worth $1.68 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares

30,849

Previous 30,847 0.01%

Holding current value

$1.68 Million

Previous $2.19 Million 1.19%

% of portfolio

0.58%

Previous 0.47%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 30, 2023	BUY	$68.48 - $81.09 $136 - $162	2 Added 0.01%	30,849 $2.22 Million
Q3 2022 Oct 17, 2022	SELL	$0.13 - $76.84 $0 - $537	-7 Reduced 0.02%	30,847 $2.19 Million
Q2 2022 Jul 13, 2022	BUY	$72.62 - $79.98 $944 - $1,039	13 Added 0.04%	30,854 $2.38 Million
Q1 2022 Apr 25, 2022	BUY	$61.48 - $73.72 $12,480 - $14,965	203 Added 0.66%	30,841 $2.25 Million
Q4 2021 Jan 25, 2022	SELL	$53.63 - $62.52 $12,174 - $14,192	-227 Reduced 0.74%	30,638 $1.91 Million
Q3 2021 Nov 02, 2021	BUY	$59.17 - $69.31 $118 - $138	2 Added 0.01%	30,865 $1.83 Million
Q2 2021 Jul 22, 2021	SELL	$61.91 - $67.42 $309 - $337	-5 Reduced 0.02%	30,863 $2.06 Million
Q1 2021 May 12, 2021	BUY	$59.34 - $66.74 $178 - $200	3 Added 0.01%	30,868 $1.95 Million
Q3 2020 Nov 10, 2020	BUY	$57.43 - $63.64 $1,148 - $1,272	20 Added 0.06%	30,865 $1.97 Million
Q2 2020 Aug 13, 2020	SELL	$54.82 - $64.09 $14,582 - $17,047	-266 Reduced 0.86%	30,845 $1.88 Million
Q1 2020 May 15, 2020	BUY	$46.4 - $67.43 $3,572 - $5,192	77 Added 0.25%	31,111 $1.9 Million
Q4 2019 Feb 12, 2020	BUY	$49.21 - $64.19 $22,144 - $28,885	450 Added 1.47%	31,034 $2.09 Million
Q3 2019 Nov 12, 2019	BUY	$42.77 - $50.71 $2,266 - $2,687	53 Added 0.17%	30,584 $1.68 Million
Q1 2019 May 09, 2019	BUY	$45.12 - $53.8 $66,191 - $78,924	1,467 Added 5.05%	30,531 $1.48 Million
Q4 2018 Feb 27, 2019	BUY	$48.76 - $63.23 $241,215 - $312,798	4,947 Added 20.51%	29,064 $1.46 Million
Q3 2018 Dec 06, 2018	BUY	$55.19 - $62.25 $4,967 - $5,602	90 Added 0.37%	24,117 $1.29 Million
Q2 2018 Jul 31, 2018	BUY	$50.53 - $62.98 $52,904 - $65,940	1,047 Added 4.56%	24,027 $1.33 Million
Q1 2018 Apr 23, 2018	BUY	$59.92 - $68.98 $2,276 - $2,621	38 Added 0.17%	22,980 $1.45 Million
Q4 2017 Mar 19, 2018	BUY	$59.94 - $65.35 $1.38 Million - $1.5 Million	22,942	22,942 $1.41 Million

Others Institutions Holding BMY

# of Institutions

2,449

Shares Held

1.51B

Call Options Held

29.7M

Put Options Held

32.1M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $115B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Burleson & Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Burleson & Company, LLC with notifications on news.

Account

Burleson & Company, LLC Bristol Myers Squibb CO Transaction History